# OnCo record methylprednisolone (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/methylprednisolone/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "methylprednisolone" ;
  schema:name "Methylprednisolone"@en ;
  schema:alternateName "methylprednisolone"@en, "methylprednisolone sodium succinate"@en, "Solu-Medrol"@en, "Solu-Medrol" ;
  schema:description "Methylprednisolone is a steroid medicine given into a vein. The WHO lists it as an essential medicine for treating lymphoid leukaemia and Burkitt lymphoma, as part of the treatment plan."@en ;
  schema:url <https://onco.cc/drugs/methylprednisolone/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://list.essentialmeds.org/medicines/114>, <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7271310c-7764-4812-aa30-a5e90987c7a9> ;
  onco:status "approved" ;
  onco:tag "universe-gap", "who-eml" ;
  onco:modality "Corticosteroid (glucocorticoid; injection)" ;
  onco:approval "WHO 2011: Essential Medicines List, hormones and antihormones: lymphoid leukaemia (2011, TRS 965); Burkitt lymphoma including Burkitt leukaemia (2021, TRS 1035)" ;
  onco:related <https://onco.cc/drugs/dexamethasone/>, <https://onco.cc/drugs/prednisone/>, <https://onco.cc/drugs/hydrocortisone/> ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/burkitt-lymphoma/> ;
  onco:targets <https://onco.cc/targets/glucocorticoid-receptor/> .
